Literature DB >> 26142586

Sickle Cell Disease in Priapism: Disparity in Care?

Gregory A Joice1, Max Kates2, Nikolai A Sopko2, Johanna L Hannan2, Trinity J Bivalacqua2.   

Abstract

OBJECTIVE: To determine the effect of sickle cell disease (SCD) on hospital resource use among patients admitted for priapism.
MATERIALS AND METHODS: Using the Nationwide Inpatient Sample, a weighted sample of 12,547 patients was selected with a primary diagnosis of priapism from 2002 to 2011. Baseline differences for patient demographics and hospital characteristics were compared between SCD and non-SCD patients. Multivariate analysis was performed to identify the effect of SCD on length of stay, use of penile operations, blood transfusion, and cost.
RESULTS: The proportion of SCD patients was 21.5%. SCD patients were younger, more often black, more likely to have Medicaid insurance, and treated more frequently in Southern urban teaching hospitals. SCD was a significant predictor of having a blood transfusion (odds ratio [OR], 16.3; P <.001), and an elongated length of stay (OR, 1.42; P <.001). SCD was associated with less penile operations (OR, 0.40; P <.001). When SCD patients did have an operation, it was performed later in the admission (mean, 0.87 vs 0.47 days; P <.001). SCD was not a significant predictor of increased cost (OR, 1.02; P = .869).
CONCLUSION: SCD patients represent a demographically distinct subgroup of priapism patients with different patterns of resource use manifested by longer hospital stays and more blood transfusions. Moreover, despite evidence that immediate treatment of priapism results in improved erectile function outcomes, SCD patients had less surgical procedures for alleviation of acute priapism events.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26142586     DOI: 10.1016/j.urology.2015.01.050

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Resolution of Acute Priapism in Two Children With Sickle Cell Disease Who Received Nitrous Oxide.

Authors:  Michael H Greenwald; Colleen K Gutman; Claudia R Morris
Journal:  Acad Emerg Med       Date:  2019-08-01       Impact factor: 3.451

Review 2.  What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel.

Authors:  S Minhas; A Salonia; M Gül; B Luca; K Dimitropoulos; P Capogrosso; U Milenkovic; A Cocci; R Veeratterapillay; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; A Kalkanli; M I Omar; C Bettocchi; J Carvalho; G Corona; T H Jones; A Kadioglu; J I Martinez-Salamanca; E C Serefoglu; P Verze
Journal:  Int J Impot Res       Date:  2022-08-08       Impact factor: 2.408

3.  Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function.

Authors:  Mateus Andrade Alvaia; Heros Aureliano Antunes da Silva Maia; Alana de Medeiros Nelli; Carina Oliveira Silva Guimarães; Evanilda Souza de Santana Carvalho; José Murillo Bastos Netto; Eduardo de Paula Miranda; Cristiano Mendes Gomes; José de Bessa Júnior
Journal:  Einstein (Sao Paulo)       Date:  2020-04-22

4.  Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises.

Authors:  Angie Mae Rodday; Kimberly S Esham; Nicole Savidge; Susan K Parsons
Journal:  EJHaem       Date:  2020-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.